Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide study.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Liver resection for hepatocellular carcinoma (HCC) patients with portal vein tumor thrombus (PVTT) offers a chance of cure, although survival is often limited. The actual 3-year survival and its associated prognostic factors have not been reported.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Hepatol Int

Title: Hepatology international

Publisher: Springer Science and Business Media LLC

ISSN (Electronic): 1936-0541

ISSN (Print): 1936-0533

Publication date (Electronic): Sep 2020

Volume: 14

Issue: 5

Affiliations

[1 ] Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, 225 Changhai Road, Shanghai, 200433, People's Republic of China.

[2 ] Chinese Liver Cancer with Portal Vein Thrombus Consortium, Shanghai, People's Republic of China.

[3 ] Department of Hepatopancreatobiliary Surgical Oncology, Military Institution of Hepatopancreatobiliary Surgery, the First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, 28 Fuxing Road, Beijing, 100853, China.

[4 ] Department of Anesthesiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, People's Republic of China.

[5 ] Department of Hepatobiliary Surgery, Affiliated Tumour Hospital of Guangxi Medical University, Nanning, People's Republic of China.

[6 ] Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.

[7 ] Department of Liver Surgery and Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, People's Republic of China.

[8 ] Department of General Surgery, Affiliated Provincial Hospital, Anhui Medical University, Hefei, People's Republic of China.

[9 ] Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, Hefei, People's Republic of China.

[10 ] Department of Hepatic Surgery, Fujian Provincial Cancer Hospital, Fujian, People's Republic of China.

[11 ] Department of Hepatobiliary Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China.

[12 ] Department of Hepatobiliary Surgery, Southern Affiliated to Hospital Southern Medical University, Guangdong, People's Republic of China.

[13 ] Department of Hepatobiliary Surgery, Foshan First People's Hospital, Guangdong, People's Republic of China.

[14 ] Department of Hepatobiliary Surgery, Inner Mongolia People's Hospital, Inner Mongolia, People's Republic of China.

[15 ] Department of Hepatobiliary Surgery, The No.940 Hospital of Joint Logistics Support Force, Gansu, People's Republic of China.

[16 ] Department of Hepatobiliary Surgery, Shanghai Public Health Center, Shanghai, People's Republic of China.

[17 ] Organ Transplant Center, Sichuan Provincial People's Hospital, Sichuan, People's Republic of China.

[18 ] Department of Oncology, The First People's Hospital of Xuzhou, Jiangsu, People's Republic of China.

[19 ] Department of General Surgery, Wenzhou People's Hospital, Zhejiang, People's Republic of China.

[20 ] Department of Hepatic Surgery, General Hospital of Northern War Zone, Liaoning, People's Republic of China.

[21 ] Second Affiliated Hospital of Wenzhou Medical University, Zhejiang, People's Republic of China.

[22 ] Department of Hepatobiliary Surgery, Affiliated Hospital of Binzhou Medical College, Shandong, People's Republic of China.

[23 ] LongYan First Hospital, Affiliated to Fujian Medical University, Fujian, People's Republic of China.

[24 ] Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, People's Republic of China.

[25 ] Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, 225 Changhai Road, Shanghai, 200433, People's Republic of China. chengshuqun@aliyun.com.

[26 ] Chinese Liver Cancer with Portal Vein Thrombus Consortium, Shanghai, People's Republic of China. chengshuqun@aliyun.com.

Article

Publisher Item ID: 10.1007/s12072-020-10032-2

DOI: 10.1007/s12072-020-10032-2

PubMed ID: 32253678

SO-VID: 8f39b9cd-0599-4faf-b85f-2e1c4ac3562e

History

Keywords: Long-term survival,Prognosis,Recurrence,Hepatocellular carcinoma,Adjuvant TACE,Portal vein tumor thrombus,Kaplan–Meier method,Nationwide study,Liver resection,Management

Data availability:

Keywords: Long-term survival, Prognosis, Recurrence, Hepatocellular carcinoma, Adjuvant TACE, Portal vein tumor thrombus, Kaplan–Meier method, Nationwide study, Liver resection, Management

Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide study.

Read this article at

Abstract

Related collections

Karger: Oncology

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 102

Cited by 17